Cargando…
Platinum-based drugs for cancer therapy and anti-tumor strategies
Platinum-based drugs cisplatin, carboplatin, and oxaliplatin are widely used for chemotherapeutic eradication of cancer. However, the side effects of platinum drugs, such as lack of selectivity, high systemic toxicity, and drug resistance, seriously limit their clinical application. With advancement...
Autores principales: | Zhang, Chunyu, Xu, Chao, Gao, Xueyun, Yao, Qingqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899578/ https://www.ncbi.nlm.nih.gov/pubmed/35265202 http://dx.doi.org/10.7150/thno.69424 |
Ejemplares similares
-
Advances in PD-1 signaling inhibition-based nano-delivery systems for tumor therapy
por: Liu, Songlin, et al.
Publicado: (2023) -
Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy
por: Buyana, Buhle, et al.
Publicado: (2022) -
Platinum-Based Nanoformulations for Glioblastoma Treatment: The Resurgence of Platinum Drugs?
por: Alfonso-Triguero, Paula, et al.
Publicado: (2023) -
Efficacy of platinum-based and non-platinum-based drugs on triple-negative breast cancer: meta-analysis
por: Lin, Canling, et al.
Publicado: (2022) -
Nanoparticle-Based Combination Therapy for Ovarian Cancer
por: Wu, Yingli, et al.
Publicado: (2023)